Business
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
MAHWAH, N.J., December 16, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the appointment of Eric Schiller as Chief Technology Officer, effective December 29, 2025.
About this update from Koru Medical Systems, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/5911ace7baad9d089dbcc581e1c49157"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/deNNTOC1mdOa07e4PrLyDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5911ace7baad9d089dbcc581e1c49157","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/t25iWy7qVOZo26q5zqjcNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/5911ace7baad9d089dbcc581e1c49157","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MAHWAH, N.J., December 16, 2025--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on developing, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the appointment of Eric Schiller as Chief Technology Officer, effective December 29, 2025.","length":430,"tagName":"p"},{"type":"text","content":"Eric joins KORU Medical with more than 25 years of leadership experience across research & development, device engineering, drug–device combination product development, supply chain strategy, and end-to-end product lifecycle management. As Chief Technology Officer, Eric will lead KORU’s product development and innovation pipeline and help shape the Company’s long-term technology and platform strategy, leveraging his experience to integrate portfolio planning with the evolving needs of KORU’s growing global customer base. He most recently served as Global Head of Device Development Portfolio at Sanofi, where he built and led a global team, advanced connected and reusable delivery platforms, drove multiple regulatory and launch-readiness initiatives, and oversaw more than 80 pipeline assets across Specialty Care, General Medicine and Vaccines.","length":857,"tagName":"p"},{"type":"text","content":"Prior to Sanofi, Eric spent more than a decade at Bristol-Myers Squibb and Celgene in roles spanning device development, biologics commercialization, and global product strategy, where he supported launches for major immunology...